Axonova is a pioneer drug discovery platform located in Mauritius. The company’s vocation is to explore and valorize the regional biodiversity, which represents a very unique ecosystem offering thousands of plants and marine species that exist nowhere else on the planet.
Axonova operates under a hybrid business model. On one hand, the company focuses on research and innovation which takes inspiration from the local biodiversity to discover new molecules with high therapeutic potential and develop a pipeline of proprietary drug candidates for brain disorders. On the other hand, the company offers drug discovery services in the field of neuroscience, ranging from proprietary natural extract libraries to cellular models and assays for pharmacological profiling and mode of action studies.
Axonova is the first company from the Sub-Saharan region to offer high-content screening services for phytotherapy applied to pharmacognosy and drug discovery.